Ireland· IE-PA-PA1968/026/001
Droperidol 1.25 mg/ml solution for injection
A droperidol product containing droperidol, registered in Ireland by Laboratoire Aguettant. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Droperidol is registered in 11 of 19 countries.
Countries holding a registration under ATC N05AD08 (droperidol), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Droperidol · ATC N05AD08
11 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Droperidol
- Manufacturer
- Laboratoire Aguettant
- Country
- Ireland (IE)
- ATC code
- N05AD08
- ATC class
- Droperidol
- Defined daily dose
- 2.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1968/026/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
273 interactions on record for droperidol.
Graded by severity as the source publishes them — 154 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Droperidol · interactions on record
273 records
- 154 severe
- 88 moderate
- 2 minor
- 27 info
Most severe, free to view
- PapaverineA03AD01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Droperidol in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandDroperidol AguettantLaboratoire Aguettant
- FranceDROLEPTAN 1,25 mg/2,5 ml, solution injectableSUBSTIPHARM
- BelgiumDehydrobenzperidol 0.5 mg/mlSubstipharm
- United KingdomDroperidol 1mg capsulesSpecial Order
- NetherlandsDehydrobenzperidol 0,5 mg/ml oplossing voor injectieSubstipharm
- SwedenDridol 2,5 mg/ml Injektionsvätska, lösningSubstipharm
- SpainDROPERIDOL AGUETTANT 2,5 MG/ML SOLUCION INYECTABLE EFGLaboratoire Aguettant
- NorwayDridolSubstipharm
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Droperidol Aguettant, Droperidol Hikma
- Belgium · Dehydrobenzperidol Substipharm, Droperidol Aguettant
- Germany · Droperidol Aguettant, Droperidol Carinopharm
- Denmark · Dehydrobenzperidol Substipharm, Droperidol Aguettant
- Spain · Droperidol Hikma, Droperidol Kalceks
- Finland · Dehydrobenzperidol Substipharm, Droperidol Aguettant
- France · Droleptan, Droperidol Aguettant
- United Kingdom (Northern Ireland) · Droperidol Hikma Farmacêutica (Portugal), Droperidol Panpharma
- Greece · Xomolix
- Hungary · Droperidol Kalceks
- Iceland · Dridol, Droperidol Aguettant
- Italy · Droperidol Kalceks, Droperidolo Aguettant
- Luxembourg · Dehydrobenzperidol Substiparm, Dehydrobenzperidol Substipharm
- Latvia · Droperidol Kalceks
- Netherlands · Dehydrobenzperidol Iv Substipharm, Dehydrobenzperidol Substipharm
- Norway · Dridol, Droperidol Aguettant
- Portugal · Droperidol Aguettant, Droperidol Hikma
- Romania · Droperidol Aguettant
- Sweden · Dridol, Droperidol Aguettant
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af4a55a4-a5b3-47ba-90ec-1b43a8aa95d6 GET /v1/drugs/af4a55a4-a5b3-47ba-90ec-1b43a8aa95d6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"N05AD08"
],
"strength": null,
"pa_number": "PA1968/026/001",
"substances": [
"Droperidol"
],
"legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "20/12/2024",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about droperidol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.